Women with large (≥3 cm) and locally advanced breast cancers (T3, 4, N1, 2, M0) receiving neoadjuvant chemotherapy (NAC: cyclophosphamide, doxorubicin, docetaxel): addition of capecitabine improves 4-year disease-free survival

PURPOSE: To determine whether capecitabine (X), combined with docetaxel (T) following doxorubicin (A) and cyclophosphamide (C), enhanced the pathological complete response (pCR) in the breast and axillary lymph nodes (ALNs) of women with large or locally advanced breast cancers (LLABCs) improving ou...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Springerplus
Main Authors: Eremin, Jennifer, Cowley, Ged, Walker, Leslie G, Murray, Elisabeth, Stovickova, Monika, Eremin, Oleg
Format: Artigo
Jezik:Inglês
Izdano: Springer International Publishing 2015
Teme:
Research
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4429427/
https://ncbi.nlm.nih.gov/pubmed/25995984
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/2193-1801-4-9
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki